WHO analysis of causes of maternal death: a systematic review
Background The reduction of maternal deaths is a key international development goal.
Evidence-based health policies and programmes aiming to reduce maternal deaths need reliable …
Evidence-based health policies and programmes aiming to reduce maternal deaths need reliable …
[PDF][PDF] The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity
S Beck, D Wojdyla, L Say, AP Betran… - Bulletin of the world …, 2010 - SciELO Public Health
OBJECTIVE: To analyse preterm birth rates worldwide to assess the incidence of this public
health problem, map the regional distribution of preterm births and gain insight into existing …
health problem, map the regional distribution of preterm births and gain insight into existing …
Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993–2005
E McLean, M Cogswell, I Egli, D Wojdyla… - Public health …, 2009 - cambridge.org
ObjectiveTo provide current global and regional estimates of anaemia prevalence and
number of persons affected in the total population and by population subgroup.Setting and …
number of persons affected in the total population and by population subgroup.Setting and …
Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America
J Villar, E Valladares, D Wojdyla, N Zavaleta, G Carroli… - The Lancet, 2006 - thelancet.com
Background Caesarean delivery rates continue to increase worldwide. Our aim was to assess
the association between caesarean delivery and pregnancy outcome at the institutional …
the association between caesarean delivery and pregnancy outcome at the institutional …
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
KAA Fox, JP Piccini, D Wojdyla, RC Becker… - European heart …, 2011 - academic.oup.com
Aims Patients with non-valvular atrial fibrillation (AF) and renal insufficiency are at increased
risk for ischaemic stroke and bleeding during anticoagulation. Rivaroxaban, an oral, direct …
risk for ischaemic stroke and bleeding during anticoagulation. Rivaroxaban, an oral, direct …
Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study
J Villar, G Carroli, N Zavaleta, A Donner, D Wojdyla… - Bmj, 2007 - bmj.com
Objective To assess the risks and benefits associated with caesarean delivery compared
with vaginal delivery. Design Prospective cohort study within the 2005 WHO global survey on …
with vaginal delivery. Design Prospective cohort study within the 2005 WHO global survey on …
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
Background Variation in and irreversibility of platelet inhibition with clopidogrel has led to
controversy about its optimum dose and timing of administration in patients with acute coronary …
controversy about its optimum dose and timing of administration in patients with acute coronary …
Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?
OBJECTIVE: Preeclampsia, gestational hypertension, and unexplained intrauterine growth
restriction may have similar determinants and consequences. In this study, we compared …
restriction may have similar determinants and consequences. In this study, we compared …
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial
KW Mahaffey, DM Wojdyla, K Carroll, RC Becker… - Circulation, 2011 - Am Heart Assoc
Background— In the Platelet Inhibition and Patient Outcomes (PLATO) trial, a prespecified
subgroup analysis showed a significant interaction between treatment and region (P=0.045), …
subgroup analysis showed a significant interaction between treatment and region (P=0.045), …
Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor …
JL Halperin, GJ Hankey, DM Wojdyla, JP Piccini… - Circulation, 2014 - Am Heart Assoc
Background— Nonvalvular atrial fibrillation is common in elderly patients, who face an
elevated risk of stroke but difficulty sustaining warfarin treatment. The oral factor Xa inhibitor …
elevated risk of stroke but difficulty sustaining warfarin treatment. The oral factor Xa inhibitor …